loadpatents
name:-0.021251916885376
name:-0.015790939331055
name:-0.27294993400574
Sullivan; Steven D.E. Patent Filings

Sullivan; Steven D.E.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Sullivan; Steven D.E..The latest application filed is for "jak kinase inhibitor compounds for treatment of respiratory disease".

Company Profile
18.12.16
  • Sullivan; Steven D.E. - San Francisco CA
  • Sullivan; Steven D. E. - South San Francisco CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Jak Kinase Inhibitor Compounds For Treatment Of Respiratory Disease
App 20220306624 - Fatheree; Paul R. ;   et al.
2022-09-29
JAK inhibitors containing a 4-membered heterocyclic amide
Grant 11,453,668 - Fatheree , et al. September 27, 2
2022-09-27
Fused Imidazo-piperidine Jak Inhibitors
App 20220289737 - Fatheree; Paul R. ;   et al.
2022-09-15
JAK kinase inhibitor compounds for treatment of respiratory disease
Grant 11,299,492 - Fatheree , et al. April 12, 2
2022-04-12
Fused imidazo-piperidine JAK inhibitors
Grant 11,254,669 - Fatheree , et al. February 22, 2
2022-02-22
Jak Inhibitors Containing A 4-membered Heterocyclic Amide
App 20210269436 - FATHEREE; PAUL R. ;   et al.
2021-09-02
Substituted Pyridines And Methods Of Use
App 20210154179 - Owens; Christina ;   et al.
2021-05-27
Alk5 Inhibitors
App 20210154178 - Kulyk; Svitlana ;   et al.
2021-05-27
Jak Kinase Inhibitor Compounds For Treatment Of Respiratory Disease
App 20210130351 - Fatheree; Paul R. ;   et al.
2021-05-06
ALK5 inhibitors
Grant 10,952,996 - Kulyk , et al. March 23, 2
2021-03-23
JAK inhibitors containing a 4-membered heterocyclic amide
Grant 10,954,237 - Fatheree , et al. March 23, 2
2021-03-23
Jak Inhibitors Containing A 4-membered Heterocyclic Amide
App 20200216447 - FATHEREE; PAUL R. ;   et al.
2020-07-09
Alk5 Inhibitors
App 20200188370 - Kulyk; Svitlana ;   et al.
2020-06-18
Fused Imidazo-piperidine Jak Inhibitors
App 20200181141 - FATHEREE; PAUL R. ;   et al.
2020-06-11
JAK inhibitors containing a 4-membered heterocyclic amide
Grant 10,550,118 - Fatheree , et al. Fe
2020-02-04
JAK kinase inhibitor compounds for treatment of respiratory disease
Grant 10,526,330 - Fatheree , et al. J
2020-01-07
Fused imidazo-piperidine JAK inhibitors
Grant 10,519,153 - Fatheree , et al. Dec
2019-12-31
Jak Inhibitors Containing A 4-membered Heterocyclic Amide
App 20190337945 - FATHEREE; Paul R. ;   et al.
2019-11-07
JAK inhibitors containing a 4-membered heterocyclic amide
Grant 10,392,386 - Fatheree , et al. A
2019-08-27
Fused Imidazo-piperidine Jak Inhibitors
App 20190127371 - FATHEREE; PAUL R. ;   et al.
2019-05-02
Jak Inhibitors Containing A 4-membered Heterocyclic Amide
App 20190119275 - FATHEREE; PAUL R. ;   et al.
2019-04-25
JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease
App 20190106420 - Fatheree; Paul R. ;   et al.
2019-04-11
Fused imidazo-piperidine JAK inhibitors
Grant 10,208,040 - Fatheree , et al. Feb
2019-02-19
JAK inhibitors containing a 4-membered heterocyclic amide
Grant 10,196,393 - Fatheree , et al. Fe
2019-02-05
JAK kinase inhibitor compounds for treatment of respiratory disease
Grant 10,100,049 - Fatheree , et al. October 16, 2
2018-10-16
Fused Imidazo-piperidine Jak Inhibitors
App 20180258088 - FATHEREE; PAUL R. ;   et al.
2018-09-13
Jak Inhibitors Containing A 4-membered Heterocyclic Amide
App 20180258087 - FATHEREE; PAUL R. ;   et al.
2018-09-13
JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease
App 20170121327 - Fatheree; Paul R. ;   et al.
2017-05-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed